For the first time, a diabetic patient was successfully treated using pancreatic extract on January 23, 1922. Those who were formerly sentenced to death might now live fairly normally.
 |
| [Insulin] |
The Nobel Committee and the Academy at the Karolinska Institute used to be a bit faster than they are now. In 1923, there was a reward for discovering insulin and the first diabetic treatments, which had barely began the previous year.
A severely emaciated 13-year-old kid lay in a bed at Toronto General Hospital a year ago, at the start of January 1922. He was already in a diabetic coma for much of the period.
From dog experiments to human therapies within weeks
However, attempts by the Romanian scientist Nicalae Paulescu had been proven in Toronto a few weeks before. For the first time, he demonstrated in diabetic dogs that this liquid, which had to include a supposed chemical called insulin, greatly improved their blood sugar levels. However, the initial attempt to rescue the youngster with a novel medication failed: on January 11, Leonard Thompson got an injection containing an extract derived from animal pancreas. However, he had a serious allergic response.
Repulsed after the setback
Not only did the Nobel Prize function differently back then than it does now. Not only that, but such trials on people with such items would no longer be permitted by any university hospital's ethical committee. The botched attempt did not set back science for years, as it is likely to do today. But just for a period of twelve days. In these twelve days, he took the critical moves ahead.
Leonard got insulin for the second time 100 years ago today, on January 23, 1922. It was a far purer substance this time, for which biochemist James Collip had worked nearly endlessly to devise a technique. Leonard not only had no adverse response this time, but the sugar in his pee had almost totally evaporated a few hours later. The youngster would now receive the preparation on a regular basis. The infant, who would have perished in a matter of weeks, recovered. Leonard lived for a further 13 years. He died of pneumonia when he was 26 years old.
From "doomed to die" to "nearly normal life"
Other early patients became the first examples of the dramatic improvements brought about by this medication – even though this was only discovered decades later: persons who had previously been condemned were able to live a largely normal life on insulin therapy. They had the same life expectancy as everyone else who did not have type 1 diabetes caused by an autoimmune disease. Elizabeth Hughes was the first American patient to be treated in Canada.
She was the Secretary of State's daughter and roughly the same age as Leonard Thompson. She did, however, survive for another 60 years. James Havens, an art student, was the first patient treated in the United States. He also survived for another four decades and rose to prominence as one of the most renowned graphic and woodcut artists in the United States.
Formerly from animals, today from bacteria
The earliest insulins utilized for medicinal purposes were derived from the pancreas of dogs and calves. Pigs were quickly added to the list of supplies. Since the 1980s, genetically modified bacteria have been used to produce a type of human insulin. There are currently a large range of versions available, such as those having a long-term impact. And the evolution continues. Doctors from the German Diabetes Society recently shared information on some of the future hopes, as well as some of the problems.
Insulin is still the only medicine that can save a person's life if they have type 1 diabetes. Many of the millions of people who have type 2 diabetes inject the hormone under their skin to manage their blood sugar levels.
Fat children desired
The 1923 Nobel Prize went to the physician Frederick Banting and the biochemist John Macleod, who had treated the first patients in Toronto. But they also felt bad about colleagues who didn't get anything. Macleod then split his prize money with that James Collip, Banting with his assistant Charles Best - who got the job with a coin toss. As always, however, important researchers were left out, above all Paulescu, who had done the crucial preliminary experimental work.
Banting maintained contact with a large number of patients. A youngster he met who was malnourished and terminally ill, for example, wrote him a letter a few months after the initial injection. He's doing well today, as Banting could see, and he's become "a pretty plump boy."